Drug Topics
OCTOBER 15, 2023
Jean-Venable R. Goode, PharmD, director of the PGY1 Community Based Residency Program at Virginia Commonwealth University, discussed the new vaccine guidelines from ACIP.
STAT
OCTOBER 15, 2023
It’s the middle of October — the time of year that’s filled with pumpkin spice lattes, jumbo-sized bags of Halloween candy, and endless advertisements to sign up for Medicare. Medicare’s annual enrollment period kicked off Sunday and runs through Dec. 7, allowing eligible older adults and people with disabilities to sign up for traditional Medicare coverage or Medicare Advantage, the alternative option that is run by health insurance companies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 15, 2023
Lindsay Constantino, president and cofounder of Centennial Pharmacy Services, an LTC pharmacy network, talks about how pharmacies can effectively market their services.
OctariusRx
OCTOBER 15, 2023
Happy Pharmacy Week to all our team members and colleagues! Each year during the third full week in October, we celebrate National Pharmacy Week and I’d like to take the time to thank our Consultant Pharmacists, as well as supporting team members. Thank you for working so hard on behalf of all our clients and patients. Your hard work enhances patient safety and patient’s lives.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
OCTOBER 15, 2023
Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN, discusses how med sync programs can help boost a pharmacy's bottom line.
pharmaphorum
OCTOBER 15, 2023
Scientists in the C-suite: Attracting investors takes more than good science Mike.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
OCTOBER 15, 2023
Pfizer launches cost-cutting drive as COVID sales fall Phil.
Med Ed 101
OCTOBER 15, 2023
At face value, metoprolol tartrate (brand name Lopressor) and metoprolol succinate (brand name Toprolol XL) may seem similar. They are both selective beta-1 adrenoceptor blockers, with tartrate being dosed twice daily and succinate being dosed once daily. However, when evaluating formulation, FDA indication, off-label indications, and pharmacokinetics, it is evident that there are a few […] The post Metoprolol Succinate Versus Tartrate appeared first on Med Ed 101.
Pharma Marketing Network
OCTOBER 15, 2023
Search Engine Optimization (SEO) is an important tool for any business, but it is especially important for pharmaceutical websites. SEO is the process of optimizing a website for higher organic reach, making it easier for potential customers to find the website. In this article, we will discuss the benefits of SEO for pharmaceutical websites, how to optimize a website for organic reach, and strategies for SEO mastery.
STAT
OCTOBER 15, 2023
On the Southeast Expressway, at the edge of the city, two billboards advertising cancer care loomed on the side of the road — one advertising Dana-Farber Cancer Institute, the other touting the work of Mass General Cancer Center. The advertisements, posted in January, were rare public evidence of the increasingly awkward relationship between two of the region’s most prominent cancer programs.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Expert insights. Personalized for you.
220 
Let's personalize your content